trial · primary record
Cysview
Bladder Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 200 |
| Primary completion | 2028-01-04 |
| Primary endpoint | Residual disease burden |
| Registry ID | NCT06525571 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:42.937Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06525571
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.